ReviewJournal of robotic surgery2026
The cyber-physical paradigm for lifetime aortic valve management: a synthesis of robotics, artificial intelligence, and augmented reality.
Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To provide a narrative synthesis of the clinical and technological evidence for a conceptual cyber-physical paradigm in aortic valve surgery, where Robotic Aortic Valve Replacement (RAVR) serves as a platform for integrated artificial intelligence (AI) and augmented reality (AR) systems. This review evaluates the thesis that this approach is poised to redefine the standard of care for the lifetime management of aortic valve disease. This review analyzes the current literature on RAVR, AI-driven decision support, and AR-guided surgery. Clinical outcomes of RAVR are critically compared to traditional and transcatheter approaches, with a focus on the growing cohort of younger, lower-risk patients. Hypothesis-generating evidence from a key propensity-matched analysis suggests that in highly selected, younger, lower-risk patients, RAVR may be associated with favorable outcomes compared to Transcatheter Aortic Valve Replacement (TAVR), including lower one-year mortality (1.4% vs. 12.5%) and rates of greater-than-mild paravalvular leak (0.7% vs. 21.5%). These observational findings must be interpreted with caution due to the potential for significant selection bias and residual confounding, and they require validation in randomized trials. Our synthesis proposes that integrating AI for predictive modeling and AR for intraoperative navigation could transform RAVR into a cohesive, data-driven therapeutic pathway. However, widespread adoption is constrained by substantial socio-technical challenges, including high capital costs, a steep learning curve confined to expert centers, and the risk of algorithmic bias. The conceptual fusion of robotics, AI, and AR represents a potential future shift in aortic valve disease management, from a craft-based art toward a data-driven science. While this integrated paradigm is not yet clinically validated, it holds the potential to enhance precision and personalize care, aiming to provide a more durable, lifetime-oriented solution for a new generation of patients.
Indexed as
Identifiers
41735593What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.